MUC1 is a cell membrane-associated mucin, expressed ubiquitously on the mucosal epithelia as well as by immune cells, that limits the inflammatory response to multiple pathogens. We have recently shown that MUC1 controls inflammation resulting from Helicobacter pylori infection by suppressing interleukin-1β (IL-1β) produced via the NLRP3 inflammasome. Here, we demonstrate that MUC1 also regulates IL-1β secretion induced by the NLRP3-activating bacteria Haemophilus influenzae but not bacteria that activate other inflammasomes. Using purified ligands, we further demonstrate that MUC1 regulation of NLRP3 is specific, as it has no effect on the NLRP1b, NLRC4 and AIM2 inflammasomes. This indicates a unique role for MUC1 in the regulation of NLRP3-activating bacterial infections.
INTRODUCTION
MUC1 is a cell-surface associated mucin that is ubiquitously expressed on multiple cell types, including epithelial and immune cells, that limits the inflammatory immune response to infection by multiple mucosal bacterial pathogens including Campylobacter jejuni, Helicobacter pylori, Pseudomonas aeruginosa and Haemophilus influenzae. [1] [2] [3] [4] MUC1 is best known as a component of the physical barrier that prevents or limits contact or colonisation by pathogens such as C. jejuni and H. pylori. 1, 2, 5 In concordance with this, MUC1 polymorphisms that result in shortened molecules are associated with H. pylori gastritis and disease. 6, 7 However, we have recently demonstrated that, surprisingly, the inflammation resulting from H. pylori infection is primarily dependent on haematopoietic expression of MUC1 and thus not due to its barrier properties. 8 The initial events following infection include the activation of pattern recognition receptors including Toll-like receptors (TLRs) that, via distinct signalling pathways, culminate in the production of cytokines. Certain cytosolic receptors activate a proteolytic complex called an inflammasome that in turn activates zymogenic caspase-1 that then converts inactive interleukin-1β (IL-1β) and IL-18 to their mature active forms. The NLRP3 inflammasome receptor is activated by a large number of stimuli including H. pylori. 9, 10 We recently demonstrated that MUC1 regulates H. pylori-induced gastritis by suppressing IL-1β production via NLRP3. 8 However, the extent to which MUC1 regulates other inflammasomes is unknown. Here, we demonstrate that MUC1 inflammasome regulation is specific to the NLRP3 inflammasome.
RESULTS AND DISCUSSION
We initially tested whether MUC1 regulates IL-1β production in response to pathogens known to activate different inflammasome complexes (Figure 1a) . Although H. pylori, H. influenzae and S. aureus are all currently understood to only activate the NLRP3 inflammasome, [10] [11] [12] P. aeruginosa activates the NLRC4 inflammasome, S. Typhimurium activates both the NLRP3 and NLRC4 inflammasomes and L. monocytogenes activates the AIM2, NLRC4 and NLRP3 inflammasomes. [13] [14] [15] The inflammasome activating ability of H. felis has not yet been described. Increased levels of IL-1β were only secreted by Muc1 −/− macrophages in response to H. pylori, H. influenzae and S. aureus (Figure 1a) . To ensure the IL-1β detected was a result of inflammasome activation and not simply pro-IL-1β released non-specifically upon cell death, we analysed the supernatants by western blotting (Figure 1b) . We found that the majority of IL-1β in the supernatant was cleaved, indicating the activation of an inflammasome (Figure 1b) . We hypothesised that, as these bacteria were those that only activate the NLRP3 inflammasome, this difference was because MUC1 has a specific role in the regulation of NLRP3 inflammasome.
Using purified ligands known to activate specific inflammasome complexes, we examined the ability of MUC1 to regulate individual inflammasome pathways. No difference was noted between wildtype and Muc1 −/− macrophages stimulated with anthrax lethal toxin (NLRP1b inflammasome), flagellin (NLRC4) or double-stranded DNA (AIM2; Figure 2a ). However, Muc1 −/− macrophages secreted increased levels of IL-1β compared with wild-type macrophages when stimulated with cytosolic muramyl dipeptide (MDP), which activates NLRP3 in mice ( Figure 2a ). We then primed cells with lipopolysaccharide and stimulated with nigericin, alum, ATP, flagellin or double-stranded DNA. Muc1 −/− macrophages secreted increased levels of IL-1β in response to the NLRP3 ligands nigericin, alum and ATP, but not flagellin or double-stranded DNA (Figure 2b ). We also assessed lactate dehydrogenase release as a correlate for cell death, a common outcome of inflammasome activation. We found that there was increased death in Muc1 −/− cells after stimulation with nigericin but not flagellin or double-stranded DNA (Figure 2c ). These data show that MUC1 specifically regulates IL-1β production and cell death via the NLRP3, but not the other inflammasomes.
The downregulation of lung inflammation in response to P. aeruginosa and H. influenzae infection is currently attributed to the ability of MUC1 to suppress TLR signalling. 3, 4 It is unlikely that suppression of the NLRP3 inflammasome is involved in MUC1 protection against P. aeruginosa pathogenesis, as P. aeruginosa does not activate NLRP3 and did not induce increased IL-1β secretion from Muc1 −/− cells. However, as H. influenzae is known to activate the NLRP3 inflammasome 11 and induced increased IL-1β secretion from Muc1 −/− cells, it is likely that the suppressive effect of MUC1 with this infection is in part due to NLRP3 inflammasome regulation.
We previously demonstrated that MUC1 has no role in regulating the severity of gastritis resulting from H. felis infection. 16 This was surprising given the important role of MUC1 in H. pylori pathogenesis. 2, 8 At the time the reason for this was unclear, as we believed that the protective effects of MUC1 were due to its physical barrier properties. Now, we believe that the reason for this is probably that MUC1 does not regulate IL-1β production in response to H. felis, perhaps indicating these bacteria either do not activate the NLRP3 inflammasome or also activate another inflammasome pathway.
The NLRP3 inflammasome is unique in that it is necessary for expression of NLRP3 to be induced by the TLR signalling cascade and NF-κB activation prior to activation. 17 We recently demonstrated that MUC1 suppresses NF-κB activation in response to lipopolysaccharide or H. pylori at the level of IRAK4, resulting in the inhibition of NLRP3 expression. 8 As IRAK4 is one of the first intermediaries in the TLR signalling cascade, MUC1 must interact with either TLRs, MyD88 or IRAK4 directly at the cell membrane. This mechanism also explains the specificity for the NLRP3 inflammasome, as other inflammasome receptors are expressed constitutively and thus would not be subject to this regulation.
In summary, we have determined that MUC1 inflammasome regulation is specific to the NLRP3 inflammasome. Extending our findings with H. pylori, this observation may be of importance for understanding the role of MUC1 in protecting against the pathogenesis of other bacteria that uniquely activate the NLRP3 inflammasome, including H. influenzae and S. aureus.
MATERIALS AND METHODS
Bacterial culture H. pylori SS1 (ref. 18) and Helicobacter felis CS1 (ref. 19) were cultivated as described previously.
2 H. influenzae type B (ATCC10211) and nontypeable (ATCC49247) were grown on chocolate agar at 37°C, 5% CO 2 . Staphylococcus aureus (ATCC29213), Salmonella Typhimurium (NCTC13347), Listeria monocytogenes (EGD) and P. aeruginosa (NCTC10662) were all grown on horse blood agar at 37°C.
Stimulation of macrophages and IL-1β quantification
Experiments involving mouse cells were performed under institutional guidelines and with approval from the University of Melbourne Animal Ethics Committee. Peritoneal macrophages from female specific-pathogen-free wild-type and Muc1 −/− 129/SvJ mice (kindly provided by Sandra Gendler; housed in the Parkville Veterinary Science animal house, University of Melbourne) 20 were collected by peritoneal lavage with 10 ml cold 2% fetal calf serum (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) in phosphatebuffered saline and cultured overnight in RPMI 1640 with 10% fetal calf serum, 1 × penicillin and streptomycin (Gibco). The next day, macrophages were stimulated with bacteria in antibiotic-free media for 2 h prior to the addition of antibiotics (penicillin, streptomycin and 50 μg ml − 1 gentamicin). Alternatively, macrophages were stimulated using E. coli lipopolysaccharide (100 ng ml ; Thermo Fisher Scientific) was used to deliver ligands intracellularly. IL-1β was quantified by ELISA as previously described. −/− macrophages (n = 5 from individual animals) were stimulated with anthrax lethal toxin (protective antigen (PA) plus lethal factor (LF)), flagellin, gDNA or MDP overnight. Lipofectamine 2000, used to deliver MDP, flagellin and dsDNA into the cell cytosol, had no effect alone on IL-1β secretion. Muc1 −/− cells secreted significantly more IL-1β than wild-type cells when stimulated with cytosolic MDP, an NLRP3 ligand (**Po0.01, *Po0.05, ANOVA). We have observed differential IL-1β secretion in response to MDP but not DNA in three independent experiments. (b) Macrophages were pulsed with LPS for 6 h then stimulated with ATP (n = 4), nigericin, alum (n = 6), flagellin (125 ng ml , n = 5). There was significantly more LDH release from Muc1 −/− cells than wild-type cells in response to the NLRP3 ligand nigericin but not flagellin or dsDNA (**Po0.01, ANOVA).
